THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 67188
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 37130
 
  
 
C07K PEPTIDES 28108
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 22103
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 17189
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1287
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 887
 
  
 
C07D HETEROCYCLIC COMPOUNDS 6156
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS246

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0198,359 METHODS AND COMPOSITIONS FOR TREATMENT OR DIAGNOSIS OF CANCERS RELATED TO GABRA3Jan 03, 17Jul 13, 17[A61K, C12Q, G01N]
2017/0049,790 COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPYMay 01, 15Feb 23, 17[A61K]
2016/0289,185 EBNA1 INHIBITORS AND THEIR METHOD OF USENov 14, 14Oct 06, 16[C07D, C07C]
2016/0282,348 METHOD FOR DIAGNOSING LUNG CANCERS USING GENE EXPRESSION PROFILES IN PERIPHERAL BLOOD MONONUCLEAR CELLSApr 02, 16Sep 29, 16[C12Q, G01N]
2016/0083,728 Methods and Compositions for Enhancing the Therapeutic Effect of Anti-Tumor T CellsDec 01, 15Mar 24, 16[A61K, C12N, A61N]
2015/0252,441 Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung CancersMay 22, 15Sep 10, 15[C12Q]
2014/0256,586 METHODS AND COMPOSITIONS FOR DIAGNOSIS OF COLORECTAL CANCERMar 07, 14Sep 11, 14[G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920375 Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancersMay 22, 15Mar 20, 18[C12Q, G01N]
9903870 Methods and compositions for the diagnosis of ovarian cancerOct 03, 13Feb 27, 18[C12Q, G01N, C40B, C07K]
9868951 Methods and compositions for enhancing the therapeutic effect of anti-tumor T cellsDec 01, 15Jan 16, 18[A61K, C12N, A61N]
9856214 EBNA1 inhibitors and their method of useNov 14, 14Jan 02, 18[A61K, C07D, C07C]
9744224 Methods for treating cancer by administration of nucleic acids encoding FAP and cancer antigensJun 23, 16Aug 29, 17[A61K]
9724393 Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferationOct 05, 16Aug 08, 17[A61K, C07D, A61P, C07K]
9724406 Constructs for enhancing immune responsesFeb 23, 15Aug 08, 17[A61K, C12N, C07K]
9675607 Epimorphic regeneration and related hydrogel delivery systemsNov 13, 14Jun 13, 17[A61K, C08G, C12N]
9624510 Adenoviral vectors comprising partial deletions of E3Feb 26, 14Apr 18, 17[C12N]
9568486 Methods and compositions for diagnosis of ectopic pregnancyFeb 15, 12Feb 14, 17[G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0000,804 Methods and Compositions for Inhibiting Mitochondrial TraffickingAbandonedJun 24, 16Jan 05, 17[A61K, C12Q, C12N, G01N]
2016/0168,144 COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF EPSTEIN-BARR NUCLEAR ANTIGEN 1AbandonedFeb 26, 16Jun 16, 16[C07D]
2016/0067,257 SCREENING METHOD AND COMPOUNDS FOR MODULATING TELOMERASE ACTIVITYAbandonedNov 19, 15Mar 10, 16[A61K, C07D]
2015/0118,257 Methods and Compositions for Manipulating the Immune SystemAbandonedMar 15, 13Apr 30, 15[C12N]
2014/0377,295 INFLUENZA VACCINES CONTAINING MODIFIED ADENOVIRUS VECTORSAbandonedMay 23, 12Dec 25, 14[C12N, C07K]
2014/0271,667 Methods and Compositions for Neoadjuvant TherapyAbandonedMar 14, 14Sep 18, 14[A61K, C07K]
2014/0272,947 METHODS AND COMPOSITIONS FOR SCREENING MODULATORS OF ONCOGENE-INDUCED SENESCENCEAbandonedMar 10, 14Sep 18, 14[C12Q]
2014/0274,794 Methods and Compositions for Diagnosis of Ovarian CancerAbandonedSep 07, 12Sep 18, 14[C12Q, G01N]
2014/0255,386 MICRORNA MODULATORS AND METHOD FOR IDENTIFYING AND USING THE SAMEAbandonedJul 24, 12Sep 11, 14[A61K, C07D, C07J]
2014/0121,127 Methods and Compositions for Diagnosis of Ovarian CancerAbandonedOct 29, 13May 01, 14[G01N]
2013/0209,512 UNIVERSAL INFLUENZA A VACCINESAbandonedAug 16, 11Aug 15, 13[C07K]
2013/0023,498 MicroRNA Modulators and Method for Identifying and Using the SameAbandonedJun 20, 12Jan 24, 13[A61K, C12N, C07D, C07C, A61P, C40B, C07J]
2013/0004,494 Inhibition of P21 and Use Thereof for Inducing Tissue RegenerationAbandonedMar 11, 11Jan 03, 13[A61K, A61P, C07K]
8304234 Compositions and methods for delivery of genetic materialExpiredDec 23, 05Nov 06, 12[A61K, C07H, C12N]
2012/0164,148 Compositions Containing JARID1B Inhibitors and Methods for Treating CancerAbandonedAug 06, 10Jun 28, 12[A61K, C12N, A61P]
2012/0141,418 Treatment of Melanoma Using HSV MutantAbandonedNov 28, 11Jun 07, 12[A61K, A61P]
2012/0010,177 MicroRNA Modulators and Method for Identifying And Using The SameAbandonedAug 01, 11Jan 12, 12[A61K, C12Q, C12N, C07D, C07C, A61P]
2011/0195,053 Treatment of Non-Neuronal Cancer using HSV-1 VariantsAbandonedApr 20, 11Aug 11, 11[A61K, A61P]
2011/0177,042 Method for Dedifferentiating MelanocytesAbandonedSep 30, 09Jul 21, 11[A61K, C12Q, C12N, A61P]
2011/0064,828 TREATMENT OF METASTATIC TUMORS AND OTHER CONDITIONSAbandonedSep 10, 10Mar 17, 11[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.